Factors associated with immunotherapy respond and survival in advanced non-small cell lung cancer patients

OBJECTIVES: This study aimed to explore factors associated with immunotherapy respond and survival in advanced non-small cell lung cancer (aNSCLC) patients treated with immune checkpoint inhibitors (ICIs). METHODS: A total of 101 patients with aNSCLC receiving ICIs were included. The association bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yahua, Wu, Haishan, Lin, Mingqiang, Liu, Tianxiu, Li, Jiancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605342/
https://www.ncbi.nlm.nih.gov/pubmed/34800914
http://dx.doi.org/10.1016/j.tranon.2021.101268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605342/
https://www.ncbi.nlm.nih.gov/pubmed/34800914
http://dx.doi.org/10.1016/j.tranon.2021.101268

Ejemplares similares